Apr 29, 2025 8:05am EDT Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update
Mar 27, 2025 8:05am EDT Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation
